GlucoTrack, Inc. (GCTK)
0.7965
-0.06
(-7.38%)
USD |
NASDAQ |
May 08, 11:50
GlucoTrack Research and Development Expense (Annual) : 9.813M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| Accuray, Inc. | 47.94M |
| Alphatec Holdings, Inc. | 76.27M |
| Boston Scientific Corp. | 2.052B |
| Plus Therapeutics, Inc. | 8.379M |